Tekla Capital Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Tekla Capital Management’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$2.8M	Hold	898,374	–	–	0.11%	103
2023 Q1	$2.3M	Hold	898,374	–	–	0.09%	117
2022 Q4	$1.34M	Hold	898,374	–	–	0.05%	126
2022 Q3	$1.56M	Hold	898,374	–	–	0.06%	118
2022 Q2	$1.17M	Hold	898,374	–	–	0.05%	130
2022 Q1	$2.14M	Hold	898,374	–	–	0.08%	123
2021 Q4	$4.12M	Hold	898,374	–	–	0.13%	107
2021 Q3	$7.28M	Sell	898,374 -143,471	-14%	-$1.23M	0.23%	91
2021 Q2	$10.2M	Hold	1,041,845	–	–	0.33%	82
2021 Q1	$9.19M	Hold	1,041,845	–	–	0.32%	82
2020 Q4	$10.7M	Hold	1,041,845	–	–	0.37%	78
2020 Q3	$9.42M	Hold	1,041,845	–	–	0.35%	66
2020 Q2	$7.44M	Buy	1,041,845 +625,179	+150%	+$6.64M	0.28%	79
2020 Q1	$3.96M	Hold	416,666	–	–	0.18%	100
2019 Q4	$5.48M	Buy	+416,666	New	+$5.08M	0.21%	96

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Tekla Capital Management's GRTX Position: Q2 2023 in Review

Tekla Capital Management held its Galera Therapeutics, Inc. Common Stock (GRTX) position steady in Q2 2023 at 898,374 shares worth $2.8M. The position accounts for 0.11% of the portfolio, ranked #103.

Tekla Capital Management first reported a position in GRTX in Q4 2019 and has held it in 15 quarters since. The position peaked at $10.7M in Q4 2020. 55 funds tracked by Wall St. Rank hold GRTX as of Q2 2023.

Tekla Capital Management held 898,374 shares of Galera Therapeutics, Inc. Common Stock worth $2.8M as of Q2 2023.
Tekla Capital Management left its Galera Therapeutics, Inc. Common Stock share count unchanged in Q2 2023.
Galera Therapeutics, Inc. Common Stock made up 0.11% of Tekla Capital Management's portfolio in Q2 2023, its #103 holding.
Tekla Capital Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and has held it in 15 quarters since.
Tekla Capital Management's Galera Therapeutics, Inc. Common Stock position peaked at $10.7M in Q4 2020.
55 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.